本文選題：微小RNA　切入點(diǎn)：糖尿病性視網(wǎng)膜病變　出處：《華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版)》2017年04期 　論文類型：期刊論文

【摘要】：目的探討miR-15a對(duì)糖尿病性視網(wǎng)膜病變抗炎和抗新生血管生成的調(diào)節(jié)作用。方法通過25mmol/L葡萄糖誘導(dǎo)人視網(wǎng)膜色素上皮細(xì)胞株HARPE-19建立高糖模型(HG),并以5mmol/L葡萄糖誘導(dǎo)的HARPE-19細(xì)胞作為對(duì)照(LG),將HG組和LG組分為4個(gè)亞組:miR-15amimic組、NC-mimic組、miR-15ainhibitor組和NC-inhibitor組,MTT增殖實(shí)驗(yàn)檢測細(xì)胞增殖能力,細(xì)胞劃痕實(shí)驗(yàn)檢測細(xì)胞遷移能力,雙熒光素酶報(bào)告基因?qū)嶒?yàn)驗(yàn)證miR-15a與酸性鞘磷脂酶(ASM)的關(guān)系,RT-PCR檢測miR-15a、ASM、VEGF、IL-1β、IL-6、TNF-αmRNA表達(dá)。結(jié)果 NC-mimic細(xì)胞和NC-inhibitor細(xì)胞中,HG組miR-15a表達(dá)均顯著低于LG組(均P0.05)。miR-15amimic組ASM mRNA表達(dá)水平顯著低于NC-mimic組(P0.05),miR-15ainhibitor組ASM mRNA表達(dá)水平顯著高于NC-inhibitor組(P0.05)。miR-15amimic組細(xì)胞遷移距離顯著大于NC-mimic組(P0.05),miR-15ainhibitor組細(xì)胞遷移距離顯著小于NC-inhibitor組(P0.05)。轉(zhuǎn)染24~120h,MTT法檢測miR-15amimic組吸光度值顯著高于NC-mimic組(P0.05),miR-15ainhibitor組吸光度值顯著低于NC-inhibitor組(P0.05)。NC-mimic細(xì)胞和NC-inhibitor細(xì)胞中,HG組VEGF、IL-1β、IL-6、TNF-αmRNA表達(dá)水平均顯著高于LG組(均P0.05)。結(jié)論降低miR-15a表達(dá)能夠促進(jìn)視網(wǎng)膜細(xì)胞炎癥反應(yīng)和血管新生,miR-15a通過炎癥反應(yīng)和血管生成雙重調(diào)節(jié)作用參與糖尿病性視網(wǎng)膜病變的發(fā)生。
[Abstract]:Objective to investigate the effects of miR-15a on anti-inflammatory and anti-angiogenesis of diabetic retinopathy. Methods High glucose glucose induced human retinal pigment epithelium cell line HARPE-19 was used to establish a high-glucose model, and HARPE-19 was induced by 5 mmol / L glucose. The HG group and LG group were divided into 4 subgroups: 1 miR-15amimic group, NC-mimiic group and NC-inhibitor group. The proliferative ability of HG group and LG group was detected by MTT assay. The cell migration ability was measured by cell scratch assay. Double luciferase reporter gene experiment confirmed the relationship between miR-15a and acid sphingolipase (ASM). RT-PCR was used to detect the expression of ASM mRNA in NC-mimic cells and NC-inhibitor cells. Results the expression of miR-15a in NC-mimic cells and NC-inhibitor cells was significantly lower than that in LG group (P 0.05. MiR-15amimic group) and ASM mRNA expression level was significantly lower than that in NC-mimic group (P0.05. MiR-15amimic group). The expression of ASM mRNA in group P0.05 miR-15ainhibitor was significantly higher than that in group NC-inhibitor (P0.05) .miR-15amimic group was significantly longer than that in group NC-mimic (P 0.05%). The absorbance of miR-15amimic group was significantly higher than that of NC-mimic group (P 0.05 miR-15aininhibitor group), and the absorbance of miR-15amimic group was significantly higher than that of NC-mimic group (P 0.05 miR-15aininhibitor group). Compared with NC-inhibitor group, the level of VEGFU IL-1 尾 IL-6 TNF- 偽 mRNA in HG group was significantly higher than that in LG group (P 0.05). Conclusion the decrease of miR-15a expression can promote the inflammatory response of retinal cells and the regulation of angiogenesis through inflammation and angiogenesis. It is involved in the development of diabetic retinopathy.
【作者單位】： 四川省西南醫(yī)科大學(xué)附屬醫(yī)院眼科;四川省德陽市人民醫(yī)院眼科;
【基金】：四川省科學(xué)技術(shù)廳科研基金資助項(xiàng)目(No.15ZC0869)
【分類號(hào)】：R587.2;R774.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前2條

1 王超;邢邯英;王杏;劉敏;張哲;;通心絡(luò)膠囊對(duì)糖尿病視網(wǎng)膜病變KK/Upj-Ay小鼠血液及視網(wǎng)膜炎性因子表達(dá)的影響[J];中國全科醫(yī)學(xué);2014年27期

2 侯陽;劉學(xué)政;張克劍;;視網(wǎng)膜Müller細(xì)胞在糖尿病視網(wǎng)膜病變發(fā)病中的作用及其研究進(jìn)展[J];山東醫(yī)藥;2010年42期

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 石佳;唐晨;呂紅彬;;miR-15a對(duì)糖尿病性視網(wǎng)膜病變抗炎和抗新生血管生成的雙重調(diào)節(jié)作用[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2017年04期

2 陳金光;;糖尿病視網(wǎng)膜病變患者外周血IL-1β和TNF-α水平檢測的臨床意義分析[J];醫(yī)學(xué)理論與實(shí)踐;2017年06期

3 楊漫溈;何剛;王丹;何曉玲;;通心絡(luò)膠囊與硝酸異山梨醇酯治療冠心病心絞痛療效體會(huì)[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2016年12期

4 桂玉敏;趙鳴;丁潔;;糖尿病視網(wǎng)膜病變發(fā)病的內(nèi)質(zhì)網(wǎng)應(yīng)激機(jī)制及羥苯磺酸鈣的治療作用研究[J];海南醫(yī)學(xué)院學(xué)報(bào);2016年11期

5 劉芳;張英來;王穎;王海英;;中醫(yī)藥治療糖尿病視網(wǎng)膜病變概況[J];實(shí)用中醫(yī)內(nèi)科雜志;2016年02期

6 曾莉蓉;陳鵬飛;魏文斌;;HSF2在潰瘍性結(jié)腸炎病灶組織中的表達(dá)及其對(duì)疾病鑒別和病情評(píng)估的價(jià)值[J];海南醫(yī)學(xué)院學(xué)報(bào);2016年11期

7 邢邯英;王超;張會(huì)欣;劉敏;王杏;;通心絡(luò)抑制KK/Upj-Ay小鼠視網(wǎng)膜組織HIF-1a/VEGF/VEGFR-2表達(dá)[J];中國實(shí)驗(yàn)方劑學(xué)雜志;2015年21期

8 蒿長英;陳明霞;郭平;馬文斌;呂海波;杜佩佩;甄林娜;劉曄;連增林;;糖網(wǎng)明目顆粒提取物對(duì)缺氧/高糖狀態(tài)下血管內(nèi)皮細(xì)胞腫瘤壞死因子-α、白細(xì)胞介素-1α表達(dá)的影響[J];中國中醫(yī)藥信息雜志;2015年08期

9 曲虹;厲泉;;高濃度葡萄糖體外對(duì)大鼠視網(wǎng)膜Müller細(xì)胞活性的影響及其機(jī)制探討[J];山東醫(yī)藥;2015年28期

10 唐思文;張彥芬;劉克劍;徐登峰;王海榮;李正杰;;連花清瘟膠囊對(duì)汽車尾氣致小鼠肺組織病理損傷及炎癥因子表達(dá)的影響[J];中國實(shí)驗(yàn)方劑學(xué)雜志;2015年13期

【二級(jí)參考文獻(xiàn)】

相關(guān)期刊論文 前3條

1 朱慧明;魏剛;張會(huì)欣;何奇龍;高學(xué)東;齊曉琳;王宏濤;;芪黃明目膠囊對(duì)糖尿病小鼠視網(wǎng)膜病變及生長因子表達(dá)的影響[J];中國全科醫(yī)學(xué);2012年30期

2 張楠;鄭遠(yuǎn)遠(yuǎn);萬鋼;呂玉潔;孫飛;卜祥雷;張譯文;要立娜;馬淑賢;袁申元;;社區(qū)糖尿病視網(wǎng)膜病變及危險(xiǎn)因素探討[J];中國全科醫(yī)學(xué);2011年26期

3 周躍華,李志輝,孫葆忱;缺血性視網(wǎng)膜損傷機(jī)制的研究〔下〕——損傷的機(jī)制和治療[J];國外醫(yī)學(xué).眼科學(xué)分冊(cè);1999年02期

，

本文編號(hào)：1613077